Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-Induced Thrombocytopenia”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableStudy completedNCT02650700
What this trial is testing

Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)

Who this might be right for
Chemotherapy in Non-Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Early research (Phase 1)Study completedNCT06523088
What this trial is testing

PN20 in Healthy Adult Volunteers

Who this might be right for
Chemotherapy-induced ThrombocytopeniaImmune Thrombocytopenic Purpura
Chongqing Peg-Bio Biopharm Co., Ltd. 27
Testing effectiveness (Phase 2)UnknownNCT05969158
What this trial is testing

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Sun Yat-sen University 90
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)UnknownNCT06099925
What this trial is testing

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07408648
What this trial is testing

A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy

Who this might be right for
Chemotherapy Induced Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 244
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Large-scale testing (Phase 3)Study completedNCT03362177
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 165
Large-scale testing (Phase 3)Study completedNCT02578901
What this trial is testing

American Trial Using Tranexamic Acid in Thrombocytopenia

Who this might be right for
Thrombocytopenia
University of Washington 330
Not applicableEnrolling By InvitationNCT06769685
What this trial is testing

TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II

Who this might be right for
CTIT-Chemotherapy Induced Thrombocytopenia
Jinhua Central Hospital 100
Large-scale testing (Phase 3)WithdrawnNCT03343847
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen
Not applicableUnknownNCT02344979
What this trial is testing

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Who this might be right for
Thrombocytopenia
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Early research (Phase 1)Active Not RecruitingNCT05426369
What this trial is testing

A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT)
Sichuan Clover Biopharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Ended earlyNCT04671901
What this trial is testing

Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, ChildhoodSolid Carcinoma
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT01516619
What this trial is testing

Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia

Who this might be right for
Non-Hodgkin Lymphoma
Andres J. M. Ferreri 3
Post-approval studies (Phase 4)UnknownNCT03633019
What this trial is testing

High-dose Use of rhTPO in CIT Patients

Who this might be right for
Thrombocytopenia
First Affiliated Hospital Xi'an Jiaotong University 50
Testing effectiveness (Phase 2)Ended earlyNCT00926354
What this trial is testing

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Who this might be right for
Chemotherapy Induced Thrombocytopenia
BioMAS Ltd 40
Not applicableLooking for participantsNCT06809101
What this trial is testing

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.

Who this might be right for
CancerCancer-related Problem/ConditionChemotherapy+3 more
Pomeranian Medical University Szczecin 265
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Next Page